Concepedia

Author

Jong‐Hyeon Jeong

University of PittsburghORCID

Also Known As

J. H. JEONG, J. H. Jeong, J. Jeong, J.-H Jeong, J.-H. Jeong, J.H Jeong, J.H. Jeong, JONG H JEONG, Jae Ki Jeong, Jeong, Jaeseok

217

Publications

17.4K

Citations

46

H-Index

146

Concepts

All Affiliations

University of PittsburghNSABP FoundationAllegheny General HospitalUPMC Hillman Cancer CenterNRG Oncology
JJ

About

Jong‐Hyeon Jeong is an author at University of Pittsburgh specializing in medicine, oncology, and breast cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

21

28

2.4K

2

Engineering

9

9

457

3

Public Health

6

6

290

4

Health Sciences

5

5

361

5

Social Sciences

1

1

65

Jong‐Hyeon Jeong

×

87

Publications

16.7K

Citations

43

H-Index

YearCitations

Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer

Bernard Fisher, Stewart Anderson, John Bryant,

New England Journal of Medicine

2002

6.1K

Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation

Bernard Fisher, Jong‐Hyeon Jeong, Stewart Anderson,

New England Journal of Medicine

2002

1.4K

Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831

Edith A. Perez, Edward H. Romond, Vera J. Suman,

Journal of Clinical Oncology

2014

984

Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31

Edith A. Perez, Edward H. Romond, Vera J. Suman,

Journal of Clinical Oncology

2011

712

Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Edward H. Romond, Jong‐Hyeon Jeong, Priya Rastogi,

Journal of Clinical Oncology

2012

514

Prognosis After Ipsilateral Breast Tumor Recurrence and Locoregional Recurrences in Five National Surgical Adjuvant Breast and Bowel Project Node-Positive Adjuvant Breast Cancer Trials

Irene Wapnir, Stewart Anderson, Eleftherios P. Mamounas,

Journal of Clinical Oncology

2006

457

Prognosis After Ipsilateral Breast Tumor Recurrence and Locoregional Recurrences in Patients Treated by Breast-Conserving Therapy in Five National Surgical Adjuvant Breast and Bowel Project Protocols of Node-Negative Breast Cancer

Stewart Anderson, Irene Wapnir, James J. Dignam,

Journal of Clinical Oncology

2009

446

Overexpression of Glut‐1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma

Martin Kunkel, Torsten E. Reichert, Peter M. Benz,

Cancer

2003

385

Patterns of Locoregional Failure in Patients With Operable Breast Cancer Treated by Mastectomy and Adjuvant Chemotherapy With or Without Tamoxifen and Without Radiotherapy: Results From Five National Surgical Adjuvant Breast and Bowel Project Randomized Clinical Trials

Alphonse G. Taghian, Jong‐Hyeon Jeong, Eleftherios P. Mamounas,

Journal of Clinical Oncology

2004

380

Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials

Bernard Fisher, Jong‐Hyeon Jeong, John Bryant,

The Lancet

2004

357

Page 1